AstraZeneca and Oracle team up on AI to find patients for drug trials
The first project targets uncontrolled high blood pressure in Abu Dhabi, with UAE healthcare company M42.
Via TNW | Business

Credit: gguy via Shutterstock.com
AstraZeneca and Oracle will use AI and real patient health data to find people for drug trials faster, the two firms announced. The deal adds to a long list of AI health tie-ups between drugmakers and tech companies.
The pair signed a non-binding term sheet, so the terms are not yet final, and neither firm said or confirmed how much money is involved.
AstraZeneca brings its know-how in drug science, trials, and regulations, while Oracle’s health…
Courtesy
This story was originally published by TNW | Business. All rights belong to the original publisher.
Read the original on thenextweb.com ↗
